All In Biotech

Drug Trial Radar · NCT05955872

A Study Evaluating the Relative Bioavailability and Food Effect of a Tablet Formulation of VX-147

A Phase 1, Open Label, Randomized, Crossover Study Evaluating the Relative Bioavailability and Food Effect of a VX-147 Test Tablet Formulation Compared to a Reference Tablet Formulation in Healthy Adult Subjects

Last checked: Nov 19, 2026Latest source record: Sep 13, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

21

Actual

Start

Jul 19, 2023

Primary completion

Sep 2, 2023

Study completion Sep 2, 2023

Sponsor

Lead sponsor
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
Sponsor type
Industry
First posted
Jul 21, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of the study is to evaluate the relative bioavailability (BA) and the effect of food on the pharmacokinetics (PK), and the safety and tolerability of VX-147 test tablet formulation.

Conditions

  • Focal Segmental Glomerulosclerosis (FSGS)

Interventions

  • VX-147Drug

    Tablets for oral administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum Observed Plasma Concentration (Cmax) of VX-147 Test Compared to VX-147 ReferenceTime frame: From Day 1 up to Day 16
  2. Area Under the Concentration Versus Time Curve From the Time of Dosing Extrapolated to Infinity (AUC0-inf) of VX-147 Test Compared to VX-147 ReferenceTime frame: From Day 1 up to Day 16
  3. Cmax of VX-147 Test Compared Under Fed Versus Fasted StateTime frame: From Day 1 up to Day 16
  4. AUC(0-inf) of VX-147 Test Compared Under Fed Versus Fasted StateTime frame: From Day 1 up to Day 16

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • ICON Salt Lake City

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.